• Chandra K, Gomes T, Blackhouse G, Kaulback K, Khan T, Ferrusi I, Yoshioka A, Levin L, Goeree R. The falls/fractures economic model in Ontario residents aged 65 years and over (FEMOR). Ontario Health Technology Assessment Series 2008;8(6). pdf
  • Blackhouse G, Xie F, Campbell K, Assasi N, Gaebel K, Levine M, Pi D, Giacomini M, Goeree R, Banks R. Intravenous immunoglobulin for treatment of idiopathic thrombocytopenic purpura: economic and health service impact analyses [Technology Report No. 112]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. pdf